Last reviewed · How we verify
Axid Capsule 150mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Axid Capsule 150mg (Axid Capsule 150mg) — Daewoong Pharmaceutical Co. LTD..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Axid Capsule 150mg TARGET | Axid Capsule 150mg | Daewoong Pharmaceutical Co. LTD. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Axid Capsule 150mg CI watch — RSS
- Axid Capsule 150mg CI watch — Atom
- Axid Capsule 150mg CI watch — JSON
- Axid Capsule 150mg alone — RSS
Cite this brief
Drug Landscape (2026). Axid Capsule 150mg — Competitive Intelligence Brief. https://druglandscape.com/ci/axid-capsule-150mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab